| Susan Lynn Chase, NP, RN, CNS | |
|
14 Pleasant St, Brunswick, ME 04011-2201 | |
| (207) 419-9221 | |
| (207) 729-0190 |
| Full Name | Susan Lynn Chase |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 14 Pleasant St, Brunswick, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346349180 | NPI | - | NPPES |
| 432055699 | Medicaid | ME |
| Entity Name | St Marys Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447226584 PECOS PAC ID: 0042107120 Enrollment ID: O20040303000236 |
News Archive
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
New figures reveal that at least 79 million ready meals and 22 million fast-food and takeaway meals are eaten weekly by adults in the UK, according to estimates in a new report by Cancer Research UK out today (Friday).
Significantly more people with mental illness and substance use disorders had insurance coverage in 2014 due to the expansion of health insurance under the Affordable Care Act, but many barriers to treatment remain, new Johns Hopkins Bloomberg School of Public Health research suggests.
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Raptor Pharmaceutical Corp., announced that the Company has acquired an exclusive worldwide license to intellectual property related to the potential treatment of Huntington's Disease from the Weizmann Institute of Science in Israel and Niigata University in Japan. In addition, Raptor has added Professor Lawrence Steinman, M.D., an inventor on the Weizmann patent, to its Advisory Board.
› Verified 2 days ago
| Entity Name | Community Clinical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164477568 PECOS PAC ID: 0042101099 Enrollment ID: O20040513000884 |
News Archive
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
New figures reveal that at least 79 million ready meals and 22 million fast-food and takeaway meals are eaten weekly by adults in the UK, according to estimates in a new report by Cancer Research UK out today (Friday).
Significantly more people with mental illness and substance use disorders had insurance coverage in 2014 due to the expansion of health insurance under the Affordable Care Act, but many barriers to treatment remain, new Johns Hopkins Bloomberg School of Public Health research suggests.
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Raptor Pharmaceutical Corp., announced that the Company has acquired an exclusive worldwide license to intellectual property related to the potential treatment of Huntington's Disease from the Weizmann Institute of Science in Israel and Niigata University in Japan. In addition, Raptor has added Professor Lawrence Steinman, M.D., an inventor on the Weizmann patent, to its Advisory Board.
› Verified 2 days ago
| Entity Name | Healthreach Community Health Centers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922071745 PECOS PAC ID: 5496726523 Enrollment ID: O20050830000720 |
News Archive
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
New figures reveal that at least 79 million ready meals and 22 million fast-food and takeaway meals are eaten weekly by adults in the UK, according to estimates in a new report by Cancer Research UK out today (Friday).
Significantly more people with mental illness and substance use disorders had insurance coverage in 2014 due to the expansion of health insurance under the Affordable Care Act, but many barriers to treatment remain, new Johns Hopkins Bloomberg School of Public Health research suggests.
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Raptor Pharmaceutical Corp., announced that the Company has acquired an exclusive worldwide license to intellectual property related to the potential treatment of Huntington's Disease from the Weizmann Institute of Science in Israel and Niigata University in Japan. In addition, Raptor has added Professor Lawrence Steinman, M.D., an inventor on the Weizmann patent, to its Advisory Board.
› Verified 2 days ago
| Entity Name | Finding Peace Of Mind Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831964154 PECOS PAC ID: 0547610834 Enrollment ID: O20231228003204 |
News Archive
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
New figures reveal that at least 79 million ready meals and 22 million fast-food and takeaway meals are eaten weekly by adults in the UK, according to estimates in a new report by Cancer Research UK out today (Friday).
Significantly more people with mental illness and substance use disorders had insurance coverage in 2014 due to the expansion of health insurance under the Affordable Care Act, but many barriers to treatment remain, new Johns Hopkins Bloomberg School of Public Health research suggests.
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Raptor Pharmaceutical Corp., announced that the Company has acquired an exclusive worldwide license to intellectual property related to the potential treatment of Huntington's Disease from the Weizmann Institute of Science in Israel and Niigata University in Japan. In addition, Raptor has added Professor Lawrence Steinman, M.D., an inventor on the Weizmann patent, to its Advisory Board.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Susan Lynn Chase, NP, RN, CNS 14 Pleasant St, Brunswick, ME 04011-2201 Ph: (207) 419-9221 | Susan Lynn Chase, NP, RN, CNS 14 Pleasant St, Brunswick, ME 04011-2201 Ph: (207) 419-9221 |
News Archive
Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and radiotherapy-induced nausea and vomiting. Zuplenz, a unique formulation of ondansetron, is the first oral soluble film approved by the FDA as a prescription medication.
New figures reveal that at least 79 million ready meals and 22 million fast-food and takeaway meals are eaten weekly by adults in the UK, according to estimates in a new report by Cancer Research UK out today (Friday).
Significantly more people with mental illness and substance use disorders had insurance coverage in 2014 due to the expansion of health insurance under the Affordable Care Act, but many barriers to treatment remain, new Johns Hopkins Bloomberg School of Public Health research suggests.
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Raptor Pharmaceutical Corp., announced that the Company has acquired an exclusive worldwide license to intellectual property related to the potential treatment of Huntington's Disease from the Weizmann Institute of Science in Israel and Niigata University in Japan. In addition, Raptor has added Professor Lawrence Steinman, M.D., an inventor on the Weizmann patent, to its Advisory Board.
› Verified 2 days ago
Peggy A Ouellette, FPMH-NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 329 Bath Rd, Brunswick, ME 04011 Phone: 800-434-3000 | |
Ms. Sheila M Hospidales, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 193 Bath Rd, Brunswick, ME 04011 Phone: 207-424-2272 | |
Jana H Christman, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 81 Medical Center Dr Ste 2150, Brunswick, ME 04011 Phone: 207-373-6155 | |
Francine Dalfonso, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 81 Medical Center Dr, 2350, Brunswick, ME 04011 Phone: 207-373-6690 Fax: 207-373-6695 | |
Renee M Powers, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 114 Bath Rd, Brunswick, ME 04011 Phone: 207-798-4400 Fax: 207-798-4452 | |
Sandra J Hayes, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3600 College Sta, Brunswick, ME 04011 Phone: 207-725-3770 Fax: 207-725-3905 | |
Fiona Neale Crouter, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 14 Maine St, Brunswick, ME 04011 Phone: 207-725-9065 |